v3.25.2
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Thousands, $ in Thousands
Parent
Common Stock
Capital in Excess of Par Value
Cumulative Net Income
Accumulated OCI
Cumulative Distributions
Non-controlling Interests
Total
Balance at beginning of period at Dec. 31, 2023 $ 881,279 $ 430 $ 991,656 $ 1,634,395 $ 6,110 $ (1,751,312) $ 34,988 $ 916,267
Balance (in shares) at Dec. 31, 2023   43,022            
Equity activity                
Issuance of common stock 4,337 $ 1 4,336         4,337
Issuance of common stock (in shares)   139            
Issuance of restricted stock   $ 2 (2)          
Issuance of restricted stock (in shares)   160            
Common Stock cash distributions ($0.57 per share) (24,616)         (24,616)   (24,616)
Stock-based compensation expense 2,202   2,202         2,202
Net income 24,230     24,230     459 24,689
Fair market valuation adjustment for interest rate swap 378       378     378
Cash paid for taxes in lieu of common shares (1,532)   (1,532)         (1,532)
Cash paid for taxes in lieu of common shares (in shares)   (50)            
Non-controlling interest distributions             (2,904) (2,904)
Non-controlling interest contributions             50 50
Other (29)   (29)         (29)
Balance at end of period at Mar. 31, 2024 886,249 $ 433 996,631 1,658,625 6,488 (1,775,928) 32,593 918,842
Balance (in shares) at Mar. 31, 2024   43,271            
Balance at beginning of period at Dec. 31, 2023 881,279 $ 430 991,656 1,634,395 6,110 (1,751,312) 34,988 916,267
Balance (in shares) at Dec. 31, 2023   43,022            
Equity activity                
Net income               44,427
Balance at end of period at Jun. 30, 2024 889,139 $ 435 1,005,468 1,677,986 5,965 (1,800,715) 93,618 982,757
Balance (in shares) at Jun. 30, 2024   43,491            
Balance at beginning of period at Mar. 31, 2024 886,249 $ 433 996,631 1,658,625 6,488 (1,775,928) 32,593 918,842
Balance (in shares) at Mar. 31, 2024   43,271            
Equity activity                
Issuance of common stock 6,521 $ 2 6,519         6,521
Issuance of common stock (in shares)   204            
Issuance of restricted stock (in shares)   16            
Common Stock cash distributions ($0.57 per share) (24,787)         (24,787)   (24,787)
Stock-based compensation expense 2,320   2,320         2,320
Net income 19,361     19,361     377 19,738
Fair market valuation adjustment for interest rate swap (523)       (523)     (523)
Non-controlling interest distributions             (377) (377)
Non-controlling interest contributions             61,025 61,025
Other (2)   (2)         (2)
Balance at end of period at Jun. 30, 2024 889,139 $ 435 1,005,468 1,677,986 5,965 (1,800,715) 93,618 982,757
Balance (in shares) at Jun. 30, 2024   43,491            
Balance at beginning of period at Dec. 31, 2024 960,627 $ 455 1,082,764 1,725,435 3,815 (1,851,842) 92,378 1,053,005
Balance (in shares) at Dec. 31, 2024   45,511            
Equity activity                
Issuance of common stock 8,411 $ 2 8,409         8,411
Issuance of common stock (in shares)   238            
Issuance of restricted stock   $ 1 (1)          
Issuance of restricted stock (in shares)   114            
Common Stock cash distributions ($0.57 per share) (27,259)         (27,259)   (27,259)
Stock-based compensation expense 2,253   2,253         2,253
Net income 20,680     20,680     1,541 22,221
Vesting of performance-based stock units   $ 2 (2)          
Vesting of performance-based stock units (in shares)   163            
Fair market valuation adjustment for interest rate swap (910)       (910)     (910)
Cash paid for taxes in lieu of common shares (4,772) $ (1) (4,771)         (4,772)
Cash paid for taxes in lieu of common shares (in shares)   (138)            
Acquisitions of non-controlling interest 2,883   2,883       (4,033) (1,150)
Non-controlling interest distributions             (2,486) (2,486)
Other (11)   (11)         (11)
Balance at end of period at Mar. 31, 2025 961,902 $ 459 1,091,524 1,746,115 2,905 (1,879,101) 87,400 1,049,302
Balance (in shares) at Mar. 31, 2025   45,888            
Balance at beginning of period at Dec. 31, 2024 960,627 $ 455 1,082,764 1,725,435 3,815 (1,851,842) 92,378 1,053,005
Balance (in shares) at Dec. 31, 2024   45,511            
Equity activity                
Net income               38,769
Balance at end of period at Jun. 30, 2025 957,507 $ 461 1,099,049 1,761,207 2,188 (1,905,398) 87,400 1,044,907
Balance (in shares) at Jun. 30, 2025   46,065            
Balance at beginning of period at Mar. 31, 2025 961,902 $ 459 1,091,524 1,746,115 2,905 (1,879,101) 87,400 1,049,302
Balance (in shares) at Mar. 31, 2025   45,888            
Equity activity                
Issuance of common stock 5,169 $ 2 5,167         5,169
Issuance of common stock (in shares)   149            
Issuance of restricted stock (in shares)   21            
Common Stock cash distributions ($0.57 per share) (26,297)         (26,297)   (26,297)
Stock-based compensation expense 2,795   2,795         2,795
Net income 15,092     15,092     1,456 16,548
Vesting of performance-based stock units (in shares)   20            
Fair market valuation adjustment for interest rate swap (717)       (717)     (717)
Cash paid for taxes in lieu of common shares (437)   (437)         (437)
Cash paid for taxes in lieu of common shares (in shares)   (13)            
Non-controlling interest distributions             (1,456) (1,456)
Balance at end of period at Jun. 30, 2025 $ 957,507 $ 461 $ 1,099,049 $ 1,761,207 $ 2,188 $ (1,905,398) $ 87,400 $ 1,044,907
Balance (in shares) at Jun. 30, 2025   46,065